3R/S-Hydroxyconopharyngine






Names

    • 3R/S-Hydroxyconopharyngine

Attributes

  • Canonical SMILES

    COC([C@]12C(NC3=C4C=C(C(OC)=C3)OC)=C4CC[N@](C5O)[C@H]1[C@H](CC)C[C@@H]5C2)=O

  • InChI

    InChI=1S/C23H30N2O5/c1-5-12-8-13-11-23(22(27)30-4)19-14(6-7-25(20(12)23)21(13)26)15-9-17(28-2)18(29-3)10-16(15)24-19/h9-10,12-13,20-21,24,26H,5-8,11H2,1-4H3/t12-,13-,20+,21?,23-/m1/s1

  • Molecule Class: Alkaloids
  • TPSA: 84.02000000000001
  • #RotBonds: 4
  • MW: 414.5020000000002
  • HBD: 2
  • HBA: 6
  • logP: 2.5908000000000007
  • Chemical Formula: C23H30N2O5


Species

    Species Place of Collection NCBI Taxonomy Voucher Specimen
    T. chippii Ivory Coast - Lg12291

External Databases


References

  • Antimicrobially active alkaloids from Tabernaemontana chippii. J Nat Prod, 1985 (PMID 4031898).

Compound-Protein Relationships

  • No relationship found

Compound Activities

    • Antimicrobial

Predicted NMR Spectral Data


Predicted MS Fragmentation Pattern

    N.B.: It is recommended to zoom in on a specific area of an MS plot before hovering on a peak.

Predicted ADMET Properties

    Property Model Name Predicted Value
    Absorption Caco-2 (logPaap) -5.2
    Human Oral Bioavailability 20% Non-Bioavailable
    Human Intestinal Absorption Absorbed
    Madin-Darby Canine Kidney -5.09
    Human Oral Bioavailability 50% Non-Bioavailable
    P-Glycoprotein Inhibitor Non-Inhibitor
    P-Glycoprotein Substrate Substrate
    Skin Permeability -0.69
    Distribution Blood-Brain Barrier (Central Nervous System) -3.24
    Blood-Brain Barrier Non-Penetrable
    Fraction Unbound (Human) 0.78
    Plasma Protein Binding 51.11
    Steady State Volume of Distribution 3.23
    Metabolism Breast Cancer Resistance Protein Non-Inhibitor
    CYP 1A2 Inhibitor Non-Inhibitor
    CYP 1A2 substrate Non-Substrate
    CYP 2C19 Inhibitor Non-Inhibitor
    CYP 2C19 substrate Non-Substrate
    CYP 2C9 Inhibitor Non-Inhibitor
    CYP 2C9 Substrate Non-Substrate
    CYP 2D6 Inhibitor Non-Inhibitor
    CYP 2D6 Substrate Non-Substrate
    CYP 3A4 Inhibitor Non-Inhibitor
    CYP 3A4 Substrate Substrate
    OATP1B1 Non-Inhibitor
    OATP1B3 Non-Inhibitor
    Excretion Clearance 8.4
    Organic Cation Transporter 2 Non-Inhibitor
    Half-Life of Drug Half-Life < 3hs
    Toxicity AMES Mutagenesis Safe
    Avian Safe
    Bee Toxic
    Bioconcentration Factor -0.07
    Biodegradation Safe
    Carcinogenesis Safe
    Crustacean Toxic
    Liver Injury I Safe
    Eye Corrosion Safe
    Eye irritation Safe
    Maximum Tolerated Dose -1.35
    Liver Injury II Toxic
    hERG Blockers Toxic
    Daphnia Maga 9.3
    Micronucleos Toxic
    NR-AhR Safe
    NR-AR Safe
    NR-AR-LBD Safe
    NR-Aromatase Safe
    NR-ER Safe
    NR-ER-LBD Safe
    NR-GR Safe
    NR-PPAR-gamma Safe
    NR-TR Safe
    T. Pyriformis -56.45
    Rat (Acute) 2.9
    Rat (Chronic Oral) 1.94
    Fathead Minnow 4.13
    Respiratory Disease Toxic
    Skin Sensitisation Safe
    SR-ATAD5 Toxic
    SR-ARE Safe
    SR-HSE Safe
    SR-MMP Safe
    SR-p53 Safe
    General Properties Boiling Point 456.99
    Hydration Free Energy -3.74
    Log(D) at pH=7.4 2.74
    Log(P) 2.07
    Log S -3.25
    Log(Vapor Pressure) -9.22
    Melting Point 223.71
    pKa Acid 8.96
    pKa Basic 6.99